IRIS
RECCHIUTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.469
AS - Asia 2.069
EU - Europa 1.866
SA - Sud America 214
AF - Africa 49
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.678
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.370
SG - Singapore 895
CN - Cina 490
IT - Italia 362
IE - Irlanda 250
SE - Svezia 222
RU - Federazione Russa 221
VN - Vietnam 221
UA - Ucraina 186
BR - Brasile 166
GB - Regno Unito 161
TR - Turchia 147
DE - Germania 138
IN - India 111
FR - Francia 106
FI - Finlandia 56
CA - Canada 53
AT - Austria 46
HK - Hong Kong 44
BD - Bangladesh 33
PL - Polonia 29
AR - Argentina 24
MX - Messico 24
JP - Giappone 23
NL - Olanda 20
KR - Corea 19
ZA - Sudafrica 16
ES - Italia 15
BE - Belgio 14
EG - Egitto 13
BZ - Belize 12
IQ - Iraq 12
AU - Australia 9
IL - Israele 9
IR - Iran 9
PK - Pakistan 9
LT - Lituania 8
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
CO - Colombia 5
KE - Kenya 5
PH - Filippine 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
EC - Ecuador 4
MA - Marocco 4
PT - Portogallo 4
TW - Taiwan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DZ - Algeria 3
GE - Georgia 3
HR - Croazia 3
PE - Perù 3
RO - Romania 3
RS - Serbia 3
AL - Albania 2
BO - Bolivia 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EU - Europa 1
FJ - Figi 1
GA - Gabon 1
HU - Ungheria 1
KH - Cambogia 1
LY - Libia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PR - Porto Rico 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 7.678
Salva come PNG Salva come JPEG
Città #
Singapore 681
San Jose 409
Chandler 366
Ashburn 293
Dublin 248
Jacksonville 229
Dallas 135
Beijing 130
New York 130
Princeton 110
Council Bluffs 100
Dearborn 94
Southend 88
Izmir 77
Santa Clara 75
Ann Arbor 74
Los Angeles 73
The Dalles 69
Ho Chi Minh City 68
Wilmington 66
Nanjing 62
Boardman 56
Pescara 55
Hanoi 52
Chieti 46
Altamura 41
Rome 39
Houston 35
Vienna 35
Tongling 34
Woodbridge 32
Hong Kong 30
Cambridge 28
Montreal 28
Hefei 26
Redondo Beach 26
Buffalo 25
Washington 25
Augusta 23
Munich 23
Nuremberg 23
Warsaw 23
Brooklyn 22
San Mateo 22
Moscow 21
Nanchang 21
São Paulo 20
Tokyo 20
Helsinki 18
Dong Ket 17
Chennai 15
Denver 15
Milan 15
Toronto 15
Brussels 13
Frankfurt am Main 13
Johannesburg 13
Naples 13
Orem 13
Central 12
Falls Church 12
Ancona 11
Cairo 11
Lappeenranta 11
Mexico City 11
Phoenix 11
Seattle 11
Shenyang 11
Tianjin 11
Amsterdam 10
Ankara 10
Jiaxing 10
Boston 9
Chicago 9
New Delhi 9
San Francisco 9
Seoul 9
Ascoli Piceno 8
Poplar 8
Shanghai 8
Stockholm 8
Da Nang 7
Kunming 7
London 7
Manchester 7
Baku 6
Changsha 6
Düsseldorf 6
Haiphong 6
Hangzhou 6
Jinan 6
Redwood City 6
Falkenstein 5
Hebei 5
Hải Dương 5
Jundiaí 5
Melbourne 5
Nairobi 5
Norwalk 5
Prato 5
Totale 4.897
Salva come PNG Salva come JPEG
Nome #
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 214
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 199
Establishment and long-term culture of human cystic fibrosis endothelial cells 197
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 192
Mechanisms of endothelial cell dysfunction in cystic fibrosis 187
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 166
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 162
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. 162
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 158
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 155
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 154
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 149
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. 146
Epigenetic regulation of the formyl peptide receptor 2 gene 146
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 145
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 143
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 143
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 141
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 139
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 137
Lipoxins, resolvins, and the resolution of inflammation 137
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 137
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 137
Lipoxin receptors 135
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 134
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 133
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 132
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 131
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. 131
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 128
Homocysteine modulates the CD40/CD40L system 127
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 127
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 126
Novel anti-inflammatory--pro-resolving mediators and their receptors. 124
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 122
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 120
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. 116
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 115
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 114
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 113
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. 109
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 105
Targeting caveolin-1 deficiency in bone marrow derived cells: A new therapeutic window for fibrotic diseases? 104
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 104
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease 101
RESOLVINS, LIPOXINS, AND MARESINS IN RESOLUTION OF INFLAMMATION 101
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 101
The Resolution Approach to Cystic Fibrosis Inflammation 100
Resolvin D1 and its GPCRs in resolution circuits of inflammation. 96
Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease 92
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 91
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 89
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 86
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 81
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 80
Specialized pro-resolving lipid mediators and resolution of viral diseases 79
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 78
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 76
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer 72
Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease 72
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 71
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 69
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 69
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 67
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 66
Nrf2 Plays a Key Role in Erythropoiesis during Aging 52
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 45
Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat 23
17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice 12
The diadenosine tetraphosphate hydrolase ApaH contributes to Pseudomonas aeruginosa pathogenicity 2
Totale 8.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022344 5 10 2 88 15 11 6 22 19 15 26 125
2022/2023958 72 133 61 105 88 170 49 64 146 12 32 26
2023/2024649 54 32 37 26 35 193 97 55 7 29 19 65
2024/20251.408 74 241 147 53 85 68 90 106 122 83 155 184
2025/20262.861 254 99 236 351 309 169 548 128 309 269 145 44
Totale 8.067